Fat free mass and exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2007 - COPD and comorbidity Year: 2007
Body composition and pulmonary function in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006
Correlation between body mass index and spirometry parameters in chronic obstructive pulmonary disease patients with ischemic heart disease and obesity. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
Body mass index, central obesity, and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Body composition in heart failure and chronic obstructive pulmonary disease patients Source: International Congress 2017 – Techniques to treat asthma Year: 2017
The ”gas-respiratory[dcdquote] index and chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 242s Year: 2003
Comorbidities and body mass index in subjects with chronic obstructive pulmonary disease Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective Source: Eur Respir J 2003; 22: 2S-4S Year: 2003
Creatinine-height index, pulmonary function and dyspnoa in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005
Body composition in chronic obstructive pulmonary disease and heart failure Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018
Lung function parameters in obese patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 78s Year: 2007
Pathophysiological features of chronic obstructive pulmonary disease in obese patients Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Cardiovascular comorbidities in chronic obstructive pulmonary disease patients Source: International Congress 2017 – COPD biomarkers Year: 2017
Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006
Smoking and dyspnea severity in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Passive smoking and epidemiology Year: 2017
Association between percentage of fat mass and endothelial function in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001
Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011